Search

everythinglearnresearchcommunity

for

Search:↓

Oral contraceptives can cause skin issues like dark patches, acne, yeast infections, sensitivity to light, spider veins, skin rashes, and hair loss.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

The document concludes that awareness and understanding of hidradenitis suppurativa are increasing, but effective treatments are still needed.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The document concludes that early diagnosis and treatment are crucial for managing skin diseases in ferrets.

Estrogen affects scalp cell types differently, enhancing some wound healing processes.

No link found between specific genes and female pattern hair loss.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Tiny particles from stem cells help activate hair growth cells and encourage hair growth in mice without being toxic.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Estrogen receptor α controls hair growth cycles and skin thickness in male mice.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.